Related Experiment Video
Updated: Oct 4, 2025
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Noncoding RNAs Interplay in Ovarian Cancer Therapy and Drug Resistance
Min Liu1, Hui Zhang1, Yanli Li1
1Lab for Noncoding RNA & Cancer, School of Life Sciences, Shanghai University, Shanghai, China.
Abstract:
Noncoding RNAs (ncRNAs) are several types of RNA that do not encode proteins, but are essential for cell regulation. Ovarian cancer (OC) is a type of gynecological cancer with a high mortality rate and a 5-year prognosis. OC is becoming more common with each passing year, and the symptoms of early-stage OC are sometimes undetectable. Meanwhile, early-stage OC has no symptoms and is difficult to diagnose. Because ncRNA has been shown to affect the development of OC and is widely distributed, it could be employed as a new biomarker for early OC. Furthermore, ncRNA has the potential to promote or inhibit drug resistance in OC, potentially giving a solution to multiple drug resistance. Various prior studies have found that different ncRNAs perform differently in OC. This article examines how mainstream ncRNAs have been expressed in OC in recent years, as well as their function in tumor growth.
Insights
Noncoding RNAs (ncRNAs) are key regulators in ovarian cancer (OC) development and drug resistance. These molecules show promise as early diagnostic biomarkers and potential therapeutic targets for this challenging gynecological cancer.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Ovarian cancer (OC) is a high-mortality gynecological cancer with often undetectable early-stage symptoms.
- Noncoding RNAs (ncRNAs) are crucial for cellular regulation and are implicated in OC development.
- Current diagnostic and treatment strategies for OC face significant challenges due to late detection and drug resistance.
Purpose of the Study:
- To review the recent expression patterns of mainstream ncRNAs in ovarian cancer.
- To elucidate the functional roles of ncRNAs in OC tumor growth and progression.
- To explore the potential of ncRNAs as early diagnostic biomarkers and therapeutic targets for OC.
Main Methods:
- Literature review of recent studies on ncRNA expression in OC.
- Analysis of functional roles of specific ncRNAs in OC cell regulation and tumor development.
- Investigation into the association between ncRNA profiles and OC drug resistance.
Main Results:
- ncRNAs are widely distributed and play diverse roles in OC development.
- Specific ncRNAs exhibit altered expression patterns in OC tissues.
- ncRNAs demonstrate potential in overcoming multidrug resistance in OC treatment.
Conclusions:
- ncRNAs represent promising biomarkers for early detection of ovarian cancer.
- Targeting ncRNAs may offer novel therapeutic strategies to combat OC and drug resistance.
- Further research into ncRNA mechanisms is essential for clinical translation in OC management.
Related Concept Videos
02:56Treatment Resistant Cancers
02:15Experimental RNAi
01:22MicroRNAs
01:23RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:20Types of RNA
RNA Performs Diverse...
02:30siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...